Sanofi Pasteur to produce Pentaxim in Russia

French pharma major Sanofi’s (Euronext: SAN) vaccines subsidiary Sanofi Pasteur has signed an agreement with the Russian pharmaceutical company Nanolek, which is part of Russian nano giant RusNano, for the establishment of production of Pentaxim, a five-in-one vaccine for the prevention of childhood diseases.

Under the terms of the agreement, the partners will invest up to 6 billion roubles ($109 million) in the production of the vaccine at the facilities of Nanolek factory in the Kirov region, reports The Pharma Letter local correspondent.

According to Elena Koltsova, head of department of corporate communications of Nanolek, the volume of production will amount to 10 million doses per year. The production will be officially started at the beginning of 2016.